BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19946103)

  • 1. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma.
    Piessen G; Wacrenier A; Briez N; Triboulet JP; Van Seuningen I; Mariette C
    J Clin Pathol; 2009 Dec; 62(12):1144-6. PubMed ID: 19946103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN; Blount PL; Sanchez CA; Cowan DS; Wongsurawat VJ; Reid BJ; Odze RD
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.
    Bax DA; Haringsma J; Einerhand AW; van Dekken H; Blok P; Siersema PD; Kuipers EJ; Kusters JG
    J Clin Pathol; 2004 Dec; 57(12):1267-72. PubMed ID: 15563666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN; Marshall RE; Owen WJ; Mason RC; Kothari D; Wilkinson ML; Sanderson JD
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the MUC1 and MUC4 expressions in thyroid papillary carcinoma.
    Baek SK; Woo JS; Kwon SY; Lee SH; Chae YS; Jung KY
    Laryngoscope; 2007 May; 117(5):911-6. PubMed ID: 17473695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F-1 overexpression correlates with decreased proliferation and better prognosis in adenocarcinomas of Barrett oesophagus.
    Evangelou K; Kotsinas A; Mariolis-Sapsakos T; Giannopoulos A; Tsantoulis PK; Constantinides C; Troupis TG; Salmas M; Kyroudis A; Kittas C; Gorgoulis VG
    J Clin Pathol; 2008 May; 61(5):601-5. PubMed ID: 17908803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of manganese superoxide dismutase expression with progression of carcinogenesis in Barrett esophagus.
    Hermann B; Li Y; Ray MB; Wo JM; Martin RC
    Arch Surg; 2005 Dec; 140(12):1204-9; discussion 1209. PubMed ID: 16365243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
    Tsutsumida H; Goto M; Kitajima S; Kubota I; Hirotsu Y; Wakimoto J; Batra SK; Imai K; Yonezawa S
    Lung Cancer; 2007 Feb; 55(2):195-203. PubMed ID: 17126950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression.
    Couvelard A; Paraf F; Gratio V; Scoazec JY; Hénin D; Degott C; Fléjou JF
    J Pathol; 2000 Sep; 192(1):14-8. PubMed ID: 10951394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
    Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.
    Burjonrappa SC; Reddimasu S; Nawaz Z; Gao X; Sharma P; Loggie B
    Indian J Cancer; 2007; 44(1):1-5. PubMed ID: 17401217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M; Moniaux N; Schmied BM; Ringel J; Friess H; Hollingsworth MA; Büchler MW; Aubert JP; Batra SK
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic vessel density in the neoplastic progression of Barrett's oesophagus to adenocarcinoma.
    Brundler MA; Harrison JA; de Saussure B; de Perrot M; Pepper MS
    J Clin Pathol; 2006 Feb; 59(2):191-5. PubMed ID: 16443737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway.
    Mariette C; Perrais M; Leteurtre E; Jonckheere N; Hémon B; Pigny P; Batra S; Aubert JP; Triboulet JP; Van Seuningen I
    Biochem J; 2004 Feb; 377(Pt 3):701-8. PubMed ID: 14583090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus.
    Bian YS; Osterheld MC; Bosman FT; Fontolliet C; Benhattar J
    Am J Clin Pathol; 2000 Oct; 114(4):583-90. PubMed ID: 11026105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ski/SnoN expression in the sequence metaplasia-dysplasia-adenocarcinoma of Barrett's esophagus.
    Villanacci V; Bellone G; Battaglia E; Rossi E; Carbone A; Prati A; Verna C; Niola P; Morelli A; Grassini M; Bassotti G
    Hum Pathol; 2008 Mar; 39(3):403-9. PubMed ID: 18261624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
    Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
    Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
    Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
    J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.